BIUNDO, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 2.865
EU - Europa 717
AS - Asia 522
AF - Africa 7
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.121
Nazione #
US - Stati Uniti d'America 2.855
IT - Italia 409
SG - Singapore 269
CN - Cina 202
DE - Germania 60
FR - Francia 55
FI - Finlandia 43
SE - Svezia 42
GB - Regno Unito 33
IN - India 20
NL - Olanda 16
RU - Federazione Russa 14
VN - Vietnam 14
CH - Svizzera 9
IE - Irlanda 8
CA - Canada 7
ES - Italia 7
JP - Giappone 5
LT - Lituania 5
EG - Egitto 4
HK - Hong Kong 4
UA - Ucraina 4
GR - Grecia 3
IR - Iran 3
SM - San Marino 3
BR - Brasile 2
CO - Colombia 2
CU - Cuba 2
DZ - Algeria 2
EU - Europa 2
NO - Norvegia 2
PE - Perù 2
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
KG - Kirghizistan 1
KR - Corea 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.121
Città #
Fairfield 435
Ashburn 269
Singapore 224
Chandler 214
Santa Clara 199
Woodbridge 182
Seattle 178
Cambridge 175
Houston 151
Wilmington 122
Boardman 113
Padova 113
Ann Arbor 76
Beijing 64
San Diego 57
Princeton 47
Medford 44
Milan 41
Rome 34
Des Moines 32
Helsinki 29
Roxbury 26
Pune 19
Dong Ket 14
London 12
Los Angeles 12
Nanjing 11
Legnaro 10
Guangzhou 9
Ogden 9
Dublin 8
Munich 8
Geneva 7
Norwalk 7
San Donà di Piave 7
Frankfurt am Main 6
Rovigo 6
Verona 6
Chita 5
Nanchang 5
Naples 5
Shenyang 5
Vicenza 5
Brendola 4
Cairo 4
Gavirate 4
Kharkiv 4
New York 4
Paris 4
Venice 4
Athens 3
Barcellona Pozzo di Gotto 3
Dallas 3
Freiburg im Breisgau 3
Hong Kong 3
Jiaxing 3
Lappeenranta 3
Las Vegas 3
Limena 3
Livorno 3
Ravenna 3
Ronco all'Adige 3
San Marino 3
Southwark 3
Tokyo 3
Turin 3
Washington 3
Wittnau 3
Abano Terme 2
Amsterdam 2
Apex 2
Bagnara Calabra 2
Barcelona 2
Bari 2
Bologna 2
Borgosesia 2
Budrio 2
Camisano Vicentino 2
Cassino 2
Changsha 2
Chicago 2
Chiswick 2
Concorezzo 2
Dueville 2
Foligno 2
Groningen 2
Hangzhou 2
Hanover 2
Havana 2
Heeze 2
Hounslow 2
Lancaster 2
Llubí 2
Macerata 2
Madrid 2
Malmo 2
Medellín 2
Messina 2
Modena 2
Oslo 2
Totale 3.147
Nome #
Overground robot assisted gait trainer for the treatment of drug-resistant freezing of gait in Parkinson disease 126
Brain structural profile of multiple system atrophy patients with cognitive impairment 115
Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia 106
Anatomical Correlates of Cognitive Functions in Early Parkinson's Disease Patients 105
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial 104
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease 102
MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study 100
Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset 100
Dynamic functional connectivity changes associated with dementia in Parkinson's disease 89
Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease 87
Double-blind randomized trial of t-DCS versus sham in Parkinson patients with mild cognitive impairment receiving cognitive training 82
Anatomical profile of cognitive impairment in MSA 81
Successful subthalamic stimulation in genetic Parkinson's disease caused by duplication of the α-synuclein gene. 81
Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study 81
Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions 79
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease 77
Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease 75
Cognitive impairment in multiple system atrophy 74
Differences in cognitive profiles between Lewy body and Parkinson’s disease dementia 74
Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study 73
The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset 73
Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown 73
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 71
Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities 69
tDCS effect on cognitive performance in Parkinson's disease 68
Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale 66
Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible? 66
Incentive-driven decision-making networks in de novo and drug-treated Parkinson's disease patients with impulsive-compulsive behaviors: A systematic review of neuroimaging studies 66
Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale 65
Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease 64
The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study 63
Reply: Dynamic functional connectivity changes in Lewy body disease 62
Can dopamine transporter imaging define early PD? 52
Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study 52
MoCA vs. MMSE sensitivity as screening instruments of cognitive impairment in PD, MSA and PSP patients 52
Effect of Intensive Rehabilitation Program in Thermal Water on a Group of People with Parkinson’s Disease: A Retrospective Longitudinal Study 50
Safety and efficacy of cognitive rehabilitation in PD with cognitive impairments 48
Erratum: Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients with Mild Cognitive Impairment Receiving Cognitive Training 47
Early DEtection of wEaring off in Parkinson disease: the DEEP study 42
null 40
Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy 40
Brain structural abnormalities in multiple system atrophy patients with cognitive impairment 39
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusion 37
Action Selection and Motor Decision Making: Insights from Transcranial Magnetic Stimulation 35
A case of childhood-onset dystonia-parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation 34
Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky Medical Adherence Scale-8 items" 34
Multimodal PET/MRI Study of Connectivity in Cognitively Impaired Patients with Parkinson’s Disease 34
Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease 33
The MTHFR C677T polymorphism modifies age at onset in Parkinson's disease 32
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion (Journal of Neurology, (2022), 269, 10, (5606-5614), 10.1007/s00415-022-11269-7) 32
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes 32
Neurocognitive correlates of numerical abilities in Parkinson’s disease 31
Brain connectivity changes associated with t‐DCS and cognitive training plus cognitive training in Parkinson's disease with mild cognitive impairment 31
Non-invasive brain stimulation to treat cognitive symptoms of Parkinson's disease. Parkinsonism 30
Anatomical and functional correlates of persistent pain in Parkinson's disease 29
Performance at the Category-Exemplars language test (CATEX) in Parkinson's disease and Huntington's disease Italian population 29
Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study 28
Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson's Disease 27
Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia 27
Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests 25
Cognitive and MRI correlates of orthostatic hypotension in Parkinson's disease 24
Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better? 24
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease 23
Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities 23
MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study 21
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort. 21
Influence of APOE status on lexical-semantic skills in mild cognitive impairment 21
Can dopamine transporter imaging define early PD? 20
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease 20
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial 20
Deep brain stimulation of globus pallidus internus and subthalamic nucleus in Parkinson’s disease: a multicenter, retrospective study of efficacy and safety 20
Overground robot assisted gait trainer for the treatment of drug-resistant freezing of gait in Parkinson disease 18
Cognitive decline in Parkinson's disease: the complex picture 18
Facial emotion recognition in individuals with mild cognitive impairment: An exploratory study 17
Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy 17
null 17
Personalized Care in Late-Stage Parkinson's Disease: Challenges and Opportunities 17
Grey matter changes in cognitively impaired Parkinson's disease patients 16
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 16
Correction to: A case of childhood‑onset dystonia‑parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation 16
Parkinson’s Disease 16
Deep brain stimulation of globus pallidus internus and subthalamic nucleus in Parkinson’s disease: a multicenter, retrospective study of efficacy and safety 16
Language-specific effects in Alzheimer's disease: Subject omission in Italian and English 16
Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS) 16
The neuroanatomical substrate of lexical-semantic decline in MCI APOE ε4 carriers and noncarriers 16
Genetic mutations in Parkinson’s disease: screening of a selected population from North-Eastern Italy 15
Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders 15
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy 13
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study 13
CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies 13
The pharmacological management of the behavioral aspects of Parkinson’s disease: an update 12
Management of psychiatric and cognitive complications in Parkinson's disease 11
Erratum: Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients with Mild Cognitive Impairment Receiving Cognitive Training (Brain Stimulation (2015) 8 (1223-1225) DOI: 10.1016/j.brs.2015.07.043) 11
Subject drop in Italian Alzheimer's disease 10
Optimal MMSE and MoCA cutoffs for cognitive diagnoses in Parkinson's disease: A data-driven decision tree model 10
Delivering Multidisciplinary Rehabilitation Care in Parkinson's Disease: An International Consensus Statement 9
Therapy-resistant symptoms in Parkinson's disease. 9
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 8
Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia 8
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease 6
Totale 4.271
Categoria #
all - tutte 25.529
article - articoli 22.576
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 469
Totale 48.574


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020284 0 0 0 0 0 34 46 55 67 35 37 10
2020/2021476 22 10 9 18 12 70 37 26 51 42 102 77
2021/2022753 135 46 43 35 15 120 31 45 32 79 39 133
2022/2023762 82 9 57 61 117 102 3 113 110 8 80 20
2023/2024725 33 93 70 43 50 120 79 55 31 26 54 71
2024/2025817 18 186 88 107 351 67 0 0 0 0 0 0
Totale 4.278